Pharos Capital Group
Status
ACTIVE
Global HQ
Dallas, United States
Countries of investment
- USA
Investment stages
- Series B
Industries
About
Pharos Capital Group is a physician-founded private equity firm dedicated to advancing the healthcare sector through strategic investments of $25 to $50 million in companies that prioritize improving patient outcomes and minimizing healthcare expenses. With a keen focus on underserved and complex communities, Pharos seeks to empower innovative healthcare solutions that address critical gaps in service delivery. The firm leverages its deep industry expertise and network to drive sustainable growth and create meaningful impact in the healthcare landscape. By aligning financial success with social responsibility, Pharos Capital Group is committed to fostering a healthier future for all.
Pharos Capital Group is a physician-founded private equity firm dedicated to advancing the healthcare sector through strategic investments of $25 to $50 million in companies that prioritize improving patient outcomes and minimizing healthcare expenses. With a keen focus on underserved and complex communities, Pharos seeks to empower innovative healthcare solutions that address critical gaps in service delivery. The firm leverages its deep industry expertise and network to drive sustainable growth and create meaningful impact in the healthcare landscape. By aligning financial success with social responsibility, Pharos Capital Group is committed to fostering a healthier future for all.
Investment Thesis
Pharos Capital Group invests in growing healthcare companies that aim to improve patient outcomes, increase access to care, and/or lower the cost of healthcare. The firm focuses on serving underserved areas, as Theyll as small and complex populations, most notably in rural and urban communities.
Manager's Experience
With a robust background in private equity, the fund manager has successfully navigated over 50 investments across healthcare and technology sectors, primarily in North America and Europe. Their strategic approach emphasizes a data-driven methodology, allowing for informed decision-making throughout the investment lifecycle. Notable exits include strategic sales to leading industry players, showcasing their ability to generate significant returns. This operator-first mindset enables a deep understanding of portfolio companies, fostering long-term growth and operational improvement.
Team
Ryan Shelton
Kneeland Youngblood
Kimberly Futrell
Joseph Acevedo
Jonathan Mazur
Joel Goldberg
Bob Crants
Anna Kovalkova
Adam Persiani
Portfolio
Complete Health
Medical Care Consortium (MCCI)
Afferent
Alereon
Aurora Imaging Technology
Egenera
Handango
Optimizely
Pioneer Surgical Technology
Reel FX Creative Studios
Renal Care 360
Time Domain